Immune-related gigantomastia: a case study

Alessia Lozito1, Maria Gemelli2, Donata Micello3

  • 1Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, MI, 20090, Italy.

Immunotherapy
|July 11, 2023
PubMed
Summary

Immune checkpoint inhibitors, like PD-1/PDL-1 blockers, can cause immune-related adverse events. This report details a rare case of gigantomastia potentially linked to this cancer immunotherapy.